PMC Isochem's R&D offers chemical, process and analytical Research and Development, up-scaling and production improvement for NCESn excipients anbd polymer for drug delivery. Thanks to a broad technology platform and lifecycle management experience, PMC Isochem's R&D team takes your product to the next level.
- Intermediates,
- APIs,
- Excipients
- Polymers for drug delivery: polyamino acid
Technologies
- Phosgenation
- Biocatalysis (enzymes)
- Hydrogenation
- Organometallic
- Peptides (solution)
- Chiral chemistry
- Hazadous reactions
- Aminoacid N-Carboxyanhydride NCA, monomers for poly-amino acids
- Ring opening polymerisation of NCAs ROP for Poly-L-Lysine, Poly-L-Glutamic, Poly-L-Aspartic, Poly-Sarcosine, Poly-L-Ornithine, Poly-L-Leucine, Poly-D-Leucine and copolymers
Strenghts
- Chemical & Process development - scale-up - improvement
- Management of Hazardous chemistry - process safety
- Product quality - cost
- Raw Material selection (supply chain) and impurities carry-over
- Analytical development, validation, GTIs
- ICH Q11 – QBD
- Ability to apply new chemistry and solutions
- Project Management in full transparency
Innovation
Considering innovation as an opportunity, PMC Isochem‘s teams are day to day seeking for new valuable solution from any field of our activity.
sdfsfgfdhggdfgfhkkjhbkjhg